Andrea Gambotto Quotations

I think this adenovirus technology is like the electric car. We all know that sooner or later we will drive an electric car. The technology just isn't quite there yet. But soon we will all be driving one.

We hope this will happen soon, because it's not nice to wait. It's a little frustrating that nobody wants to spend the money, that nobody wants this to become real.

Using this technology we can have much broader protection, which is important because the virus is always changing.

We have the technique to go from an email to a virus.

Bird flu may likely become the next pandemic, and this vaccine is worth investigating further.

Bird flu is something we should be prepared for, but even if a pandemic never happens, everything we learn now from this vaccine can be applied to vaccines for other emerging infectious diseases.

The results of this animal trial are very promising, not only because our vaccine completely protected animals that otherwise would have died, but also because we found that one form of the vaccine stimulates several lines of immunity against H5N1.

Some people would say you were crazy if you were to say you were making a vaccine as a way to make money for the university. It could happen.

This is a very potent vaccine. The results of this animal trial are very promising.

This is a very potent vaccine. It took roughly about 30 days to make the vaccine from when we received the sequence information from CDC in Atlanta.

Eventually we will need to partner with a company for large-scale production of vaccine.

That means there is a lot of chance of getting cross-reactivity.

It takes a little over a month for us to develop a recombinant vector vaccine compared to a minimum of several months via traditional methods. This capacity will be particularly invaluable if the virus begins to mutate rapidly, a phenomenon that often limits the ability of traditional vaccines to contain outbreaks of mutant strains.

In humans, the H5N1 bird flu takes about two weeks to kill, so there is time for T cells to come out and give protection.

And if avian flu develops into a pandemic human strain - as many experts fear it may - the vaccine might complement traditional vaccines and be used to protect people.